The Presence of Insulin-degrading Enzyme in Human Ileal and Colonic Mucosal Cells

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 11, 1996, Pages 1180-1184

  Bai, Jane P F ^a   Hong, Hae Jin ^a   Rothenberger, David A ^b   Douglas Wong, W ^b   Buls, John G ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; HYPERGLYCEMIC AGENT; INSULIN; INSULINASE;

ANIMAL; ARTICLE; CELL STRAIN CACO 2; COLON; CYTOSOL; DRUG EFFECT; ENZYMOLOGY; HUMAN; ILEUM; INTESTINE MUCOSA; METABOLISM; MOUSE; PH; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; COLON; CYTOSOL; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; ILEUM; INSULIN; INSULIN ANTAGONISTS; INSULYSIN; INTESTINAL MUCOSA; MICE;

EID: 0030279348     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03917.x     Document Type: Article

References (36)

1. Affholter, J. A., Hsieh, C. L., Francke, U., Roth, R. A. (1990) Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Mol. Endocrinol. 4: 1125-1135
2. Arrigo, A. P., Tanaka, K., Goldberg, A. L., Welch, W. J. (1988) Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome). Nature 331: 192-194
3. Atchison, J. A., Grizzle, W. E., Pillion, D. J. (1989) Colonic absorption of insulIn: an in vitro and in vivo evaluation. J. Pharmacol. 248: 567-572
4. Bai, J. P. F., Chang, L. L. (1995) Transepithelial transport of insulIn: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm. Res. 12: 1171-1175
5. Bai, J. P. F., Chang, L. L., Guo, J. H. (1995a) Effects of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon. J. Pharm. Sci. 84: 1291-1294
6. Bai, J. P. F., Hsu, M. J. P., Shier, W. T. (1995b) Insulin-degrading enzyme in a human colon adenocarcinoma cell (Caco-2). Pharm. Res. 12: 513-517
7. Bendayan, M., Ziv, E., Ben, S. R., Bar, O. H., Kidron, M. (1990) Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia 33: 197-204
8. Bendayan, M., Ziv, E., Gingras, D., Ben, S. R., Bar, O. H., Kidron, M. (1994) Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia 37: 119-126
9. Bohe, M., Borgstrom, A., Genell, S., Ohlsson, K. (1983) Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human faeces and ileostomy drainage. Digestion 27: 8-12
10. Brondsted, H., Hovgaard, L. (1993) A novel hydrogel system designed for controlled drug delivery to the colon, Proc Int. Symp. Contr. Rel. Bioact. Mater. 20: 178-179
11. Chang, L. L., Rothenberger, D. A., Wong, D. W., Buls, J. W., Shier, T. W., Bai, J. P. F. (1996) Immunohistochemical localization of insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma cell line (Caco-2), and in human ileum. J. Pharm. Sci. In press
12. Duckworth, W. C. (1988) Insulin degradation: mechanisms, products, and significance. Endocr. Rev. 9: 319-345
13. Duckworth, W. C. (1990) Insulin degrading enzyme In: Cuatrecasas, P., Jacobs, S. (eds) Insulin, Springer-Verlag, Berlin, pp 143-181
14. Duckworth, W. C., Heinemann, M. A., Kitabchi, A. (1972) Purification of insulin-specific protease by affinity chromatography. Proc. Natl. Acad. Sci. 69: 3698-3702
15. Duckworth, W. C., Hamel, F. G., Liepnieks, J., Peavy, D., Frank, B., Rabkin, R. (1989) Insulin degradation products from perfused rat kidney. Am. J. Physiol. 256: E208-E214
16. Duckworth, W. C., Hamel, F. G., Bennett, R., Ryan, M. P., Roth, R. A (1990) Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. J. Biol. Chem. 265: 2984-2987
17. Gallo-Payet, N., Hugon, J. S. (1984) Insulin receptors in isolated adult mouse intestinal cells: studies in vivo and in organ culture. Endocrinol. 114: 1885-1892
18. 125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody. Endocrinology 120: 829-831
19. Kuo, W. L., Montag, A. G., Rosner, M. R. (1993) Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinol. 132: 604-611
20. Lundin, S., Pantzar, N., Broeders, A., Ohlin, M., Westrom, B. R. (1981) Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small intestine of the rat. Pharm. Res. 8: 1274-1280
21. Lundin, S., Vilhardt, H. (1986) Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits. Acta Endocrinol. 112: 457-460
22. Milojevic, S., Newton, J. M., Cummings, J. H., Gibson, G., Botham, R. L., Ring, S. G., Allwood, M., Stockham, M. (1993). In vitro and in vivo evaluation of amylose coated pellets for colon specific drug delivery Proc. Int. Symp. Contr. Rel. Bioact. Mater. 20: 288-289
23. Morishita, I., Morishita, M., Takayama, K., Machida, Y., Nagai, T. (1993a) Enterai insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int. J. Pharm. 91: 29-33
24. 2EDTA and sodium glycocholate on intestinal absorption of insulin. Biol. Pharm. Bull. 16: 68-72.
25. Muir, A., Luchetta, R., Schatz, D. (1992) Insulin-specific immunotherapy ameliorates diabetes in non-obese diabetic (NOD) mice. Diabetes, 41 (Suppl): 39A
26. Pillion, D. J., Ganapathy, V., Leibach, F. H. (1985) Identification of insulin receptors on the mucosal surface of colon epithelial cells J. Biol. Chem. 260: 5244-5247
27. Roth, R. A., Mesirow, M. L., Cassell, D. J., Yokono, K., Baba, S. (1985) Characterization of an insulin-degrading enzyme from cultured human lymphocytes. Diabetes Res. Clin. Pract. 1: 31-39
28. Rubinstein, A., Radai, R., Ezra, M., Pathak, S., Rokem, J. S. (1993) In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm. Res. 10: 258-263
29. Saffran, M., Kumar, G. S., Savarlar, C., Burnham, J. C., Williams, F., Neckers, D. C. (1986) A new approach to the oral administration of insulin and other peptide drugs. Science 233: 1081-1084
30. Shii, K., Roth, R. A. (1986) Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc. Natl Acad. Sci. 83: 4147-4151
31. Shii, K., Yokono, K., Bara, S., Roth, R. A. (1986) Purification and characterization of insulin-degrading enzyme from human erythrocytes. Diabetes 35: 675-683
32. Sonne, O. (1985) Receptor-mediated degradation and internalization of insulin in the adenocarcinoma cell line HT-29 from human colon. Mol. Endocrinol. 39: 39-48
33. Tsuji, A., Kurachi, K. (1989) Isolation and characterization of a novel large protease accumulated in mammalian cells in the presence of inhibitors. J. Biol. Chem. 264: 16093-16099
34. Yamamoto, A., Hayakawa, E., Lee, V. H. L. (1990) Insulin and proinsulin proteolysis in mucosal homogenates of the rabbit: implications in peptide delivery from nonoral routes. Life Sci. 47: 2465-2474
35. Yokono, K., Imamura, Y., Shii, K., Sakai, H., Baba, S. (1981) Purification and characterization of insulin-degrading enzyme from pig skeletal muscle. Endocrinology 108: 1527-1532
36. Zhang, Z. J., Davidson, L., Eisenbarth, G., Weiner, H. L. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl Acad. Sci. 88: 10252-10256